Page last updated: 2024-08-25

adriamycinol and Cardiac Diseases

adriamycinol has been researched along with Cardiac Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvey, SJ; Bedja, D; Cardounel, AJ; Gabrielson, KL; Olson, LE; Reeves, RH1
Brown, AM; Bryant, J; Dakhil, SR; Davidson, NE; Fehrenbacher, L; Geyer, CE; Ingle, JN; Jenkins, RB; Kaufman, PA; Klein, PM; Kutteh, LA; Lingle, WL; Mamounas, EP; Martino, S; Paik, S; Perez, EA; Pisansky, TM; Romond, EH; Suman, VJ; Swain, SM; Tan-Chiu, E; Visscher, DW; Vogel, VG; Wolmark, N; Yothers, G1
Donthamsetty, S; Latendresse, JR; Mehendale, HM; Mitra, MS; White, B1
Forrest, GL; Gonzalez, B; Li, X; Mann, J; Tseng, W1
Bernardini, C; Danesi, R; Del Tacca, M; Ducci, M; Romanini, A1

Trials

1 trial(s) available for adriamycinol and Cardiac Diseases

ArticleYear
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
    The New England journal of medicine, 2005, Oct-20, Volume: 353, Issue:16

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Heart Diseases; Humans; Mastectomy; Middle Aged; Paclitaxel; Proportional Hazards Models; Receptor, ErbB-2; Recurrence; Survival Analysis; Trastuzumab

2005

Other Studies

4 other study(ies) available for adriamycinol and Cardiac Diseases

ArticleYear
Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1.
    Cancer research, 2003, Oct-15, Volume: 63, Issue:20

    Topics: Alcohol Oxidoreductases; Alleles; Animals; Antibiotics, Antineoplastic; Doxorubicin; Electrocardiography; Female; Heart; Heart Diseases; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Myocardium; Pregnancy; Weight Loss

2003
Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity.
    Toxicology and applied pharmacology, 2007, Nov-15, Volume: 225, Issue:1

    Topics: Adenosine Triphosphate; Adiponectin; AMP-Activated Protein Kinases; Animals; Antibiotics, Antineoplastic; Diet; Doxorubicin; Fatty Acids; Gene Expression Regulation; Heart Diseases; Ion Channels; Janus Kinases; Male; Mitochondrial Proteins; Multienzyme Complexes; Oxidation-Reduction; Oxidative Stress; PPAR alpha; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Uncoupling Protein 2; Uncoupling Protein 3

2007
Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
    Cancer research, 2000, Sep-15, Volume: 60, Issue:18

    Topics: Alcohol Oxidoreductases; Animals; Antibiotics, Antineoplastic; Creatine Kinase; Disease Models, Animal; Doxorubicin; Electrocardiography, Ambulatory; Heart Diseases; Humans; Immunohistochemistry; Mice; Mice, Inbred Strains; Mice, Transgenic; Microscopy, Electron; Mitochondria, Heart; Myocardium; Organ Specificity

2000
Might adriamycinol contribute to adriamycin-induced cardiotoxicity?
    Pharmacological research communications, 1985, Volume: 17, Issue:11

    Topics: Animals; Doxorubicin; Electrocardiography; Heart Diseases; Kinetics; Male; Rats; Rats, Inbred Strains; Time Factors

1985